Lenshil Lenvatinib Capsules 4mg

Advanced thyroid cancer and advanced renal cell carcinoma (kidney cancer) are both conditions that are treated with the prescription drug lenvatinib capsules 4mg. Lenvatinib, a tyrosine kinase inhibitor that inhibits tumour blood vessel formation and slows the proliferation of cancer cells, is the substance's active component. The capsules are ingested once each day. Hypertension, exhaustion, diarrhoea, and hand-foot syndrome are typical side effects. Heart attacks, liver issues, and slowed wound healing are examples of serious side effects. Throughout treatment, regular medical monitoring is required. For safe and effective use, patients should closely adhere to the specified dosage and instructions as well as communicate any troubling symptoms to their healthcare professional.